Assessing Therapeutic Efficacy in Real-time by Hyperpolarized Magnetic Resonance Metabolic Imaging

Precisely measuring tumor-associated alterations in metabolism clinically will enable the efficient assessment of therapeutic responses. Advances in imaging technologies can exploit the differences in cancer-associated cell metabolism as compared to normal tissue metabolism, linking changes in target metabolism to therapeutic efficacy. Metabolic imaging by Positron Emission Tomography (PET) employing 2-fluoro-deoxy-glucose ([18F]FDG) has been used as a routine diagnostic tool in the clinic. Recently developed hyperpolarized Magnetic Resonance (HP-MR), which radically increases the sensitivity of conventional MRI, has created a renewed interest in functional and metabolic imaging. The successful translation of this technique to the clinic was achieved recently with measurements of 13C-pyruvate metabolism. Here, we review the potential clinical roles for metabolic imaging with hyperpolarized MRI as applied in assessing therapeutic intervention in different cancer systems.

[1]  R. Davis,et al.  Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype , 2020, Cancer Immunology Research.

[2]  C. Wood,et al.  Assessing Metabolic Intervention with a Glutaminase Inhibitor in Real-Time by Hyperpolarized Magnetic Resonance in Acute Myeloid Leukemia , 2019, Molecular Cancer Therapeutics.

[3]  C. Wood,et al.  Real-Time Interrogation of Aspirin Reactivity, Biochemistry, and Biodistribution by Hyperpolarized Magnetic Resonance Spectroscopy. , 2019, Angewandte Chemie.

[4]  Christoffer Laustsen,et al.  Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology , 2018, Neoplasia.

[5]  J. Hsieh,et al.  Hyperpolarized MRI Visualizes Warburg Effects and Predicts Treatment Response to mTOR Inhibitors in Patient-Derived ccRCC Xenograft Models. , 2018, Cancer research.

[6]  S. Aime,et al.  Metabolic Studies of Tumor Cells Using [1-13 C] Pyruvate Hyperpolarized by Means of PHIP-Side Arm Hydrogenation. , 2018, Chemphyschem : a European journal of chemical physics and physical chemistry.

[7]  P. Troncoso,et al.  Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In Vivo , 2019, Molecular Imaging and Biology.

[8]  Alexej Jerschow,et al.  Parahydrogen-Based Hyperpolarization for Biomedicine. , 2018, Angewandte Chemie.

[9]  Matthew S. Adams,et al.  Assessing high‐intensity focused ultrasound treatment of prostate cancer with hyperpolarized 13C dual‐agent imaging of metabolism and perfusion , 2018, NMR in biomedicine.

[10]  A. Venkatesan,et al.  Influence of parameter accuracy on pharmacokinetic analysis of hyperpolarized pyruvate , 2018, Magnetic resonance in medicine.

[11]  James B. Mitchell,et al.  Hyperpolarized [1-13C]-Pyruvate Magnetic Resonance Spectroscopic Imaging of Prostate Cancer In Vivo Predicts Efficacy of Targeting the Warburg Effect , 2018, Clinical Cancer Research.

[12]  K. Keshari,et al.  Targeted AKT Inhibition in Prostate Cancer Cells and Spheroids Reduces Aerobic Glycolysis and Generation of Hyperpolarized [1-13C] Lactate , 2018, Molecular Cancer Research.

[13]  C. Thompson,et al.  In Vivo Imaging of Glutamine Metabolism to the Oncometabolite 2-Hydroxyglutarate in IDH1/2 Mutant Tumors. , 2017, Cell metabolism.

[14]  Rahul Aggarwal,et al.  Hyperpolarized 1-[13C]-Pyruvate Magnetic Resonance Imaging Detects an Early Metabolic Response to Androgen Ablation Therapy in Prostate Cancer. , 2017, European urology.

[15]  P. Bhattacharya,et al.  Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer , 2017, Scientific Reports.

[16]  C. Logothetis,et al.  Targeting of CYP17A1 Lyase by VT-464 Inhibits Adrenal and Intratumoral Androgen Biosynthesis and Tumor Growth of Castration Resistant Prostate Cancer , 2016, Scientific Reports.

[17]  C. Najac,et al.  Detection of inflammatory cell function using 13C magnetic resonance spectroscopy of hyperpolarized [6-13C]-arginine , 2016, Scientific Reports.

[18]  P. Bhattacharya,et al.  Bio-interfacial magnetic resonance imaging of hyperpolarized contrast agents for metabolic flux interrogation in vivo , 2016 .

[19]  J. Bankson,et al.  Use of a Multi-compartment Dynamic Single Enzyme Phantom for Studies of Hyperpolarized Magnetic Resonance Agents. , 2016, Journal of visualized experiments : JoVE.

[20]  Martin J. Graves,et al.  A comparison of quantitative methods for clinical imaging with hyperpolarized 13C‐pyruvate , 2016, NMR in biomedicine.

[21]  W. Perman,et al.  Towards Real-time Metabolic Profiling of Cancer with Hyperpolarized Succinate , 2016, Journal of molecular imaging & dynamics.

[22]  J. Velez,et al.  Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models , 2015, Clinical Cancer Research.

[23]  Marc S Ramirez,et al.  Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors. , 2015, Cancer research.

[24]  K. Baggerly,et al.  Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers , 2015, Clinical Cancer Research.

[25]  J. Kurhanewicz,et al.  Metabolic response of prostate cancer to nicotinamide phophoribosyltransferase inhibition in a hyperpolarized MR/PET compatible bioreactor , 2015, The Prostate.

[26]  John Kurhanewicz,et al.  Real‐time measurement of hyperpolarized lactate production and efflux as a biomarker of tumor aggressiveness in an MR compatible 3D cell culture bioreactor , 2015, NMR in biomedicine.

[27]  R. Gillies,et al.  Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function. , 2015, Cancer research.

[28]  E. Terreno,et al.  Probing treatment response of glutaminolytic prostate cancer cells to natural drugs with hyperpolarized [5‐13C]glutamine , 2015, Magnetic resonance in medicine.

[29]  E. Chekmenev,et al.  Hyperpolarization of “Neat” Liquids by NMR Signal Amplification by Reversible Exchange , 2015, The journal of physical chemistry letters.

[30]  James B. Mitchell,et al.  13C-MR Spectroscopic Imaging with Hyperpolarized [1-13C]pyruvate Detects Early Response to Radiotherapy in SCC Tumors and HT-29 Tumors , 2015, Clinical Cancer Research.

[31]  Silvio Aime,et al.  ParaHydrogen Induced Polarization of 13C carboxylate resonance in acetate and pyruvate , 2015, Nature Communications.

[32]  D. Piwnica-Worms,et al.  Chemical reaction-induced multi-molecular polarization (CRIMP). , 2014, Chemical communications.

[33]  J. Brooks,et al.  The feasibility of assessing branched-chain amino acid metabolism in cellular models of prostate cancer with hyperpolarized [1-(13)C]-ketoisocaproate. , 2014, Magnetic resonance imaging.

[34]  S. Josan,et al.  Hyperpolarized [1,4‐13C]‐diethylsuccinate: a potential DNP substrate for in vivo metabolic imaging , 2014, NMR in biomedicine.

[35]  David M. Wilson,et al.  Chemistry and biochemistry of 13C hyperpolarized magnetic resonance using dynamic nuclear polarization. , 2014, Chemical Society reviews.

[36]  R. Gillies,et al.  Monitoring chemotherapeutic response by hyperpolarized 13C-fumarate MRS and diffusion MRI. , 2014, Cancer research.

[37]  Daniel B Vigneron,et al.  Non-invasive in vivo assessment of IDH1 mutational status in glioma , 2013, Nature Communications.

[38]  P. Larson,et al.  Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-13C]Pyruvate , 2013, Science Translational Medicine.

[39]  R. Gillies,et al.  Evaluation of LDH-A and glutaminase inhibition in vivo by hyperpolarized 13C-pyruvate magnetic resonance spectroscopy of tumors. , 2013, Cancer research.

[40]  Shingo Matsumoto,et al.  EPR oxygen imaging and hyperpolarized 13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3‐bromopyruvate , 2013, Magnetic resonance in medicine.

[41]  S. Ronen,et al.  Treatment with the MEK inhibitor U0126 induces decreased hyperpolarized pyruvate to lactate conversion in breast, but not prostate, cancer cells , 2013, NMR in biomedicine.

[42]  Albert P. Chen,et al.  Probing Early Tumor Response to Radiation Therapy Using Hyperpolarized [1-13C]pyruvate in MDA-MB-231 Xenografts , 2013, PloS one.

[43]  Y. Wang,et al.  Glycolytic Inhibition Alters Anaplastic Thyroid Carcinoma Tumor Metabolism and Improves Response to Conventional Chemotherapy and Radiation , 2012, Molecular Cancer Therapeutics.

[44]  B. Ross,et al.  Real-time molecular imaging of tricarboxylic acid cycle metabolism in vivo by hyperpolarized 1-(13)C diethyl succinate. , 2012, Journal of the American Chemical Society.

[45]  Kristen Scott,et al.  Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma , 2012, NeuroImage.

[46]  P. Troncoso,et al.  Modeling a Lethal Prostate Cancer Variant with Small-Cell Carcinoma Features , 2011, Clinical Cancer Research.

[47]  John Kurhanewicz,et al.  Hyperpolarized 13C dehydroascorbate as an endogenous redox sensor for in vivo metabolic imaging , 2011, Proceedings of the National Academy of Sciences.

[48]  Peder E. Z. Larson,et al.  13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression. , 2011, Cell metabolism.

[49]  F. Gallagher,et al.  Hyperpolarized [1-13C]-Ascorbic and Dehydroascorbic Acid: Vitamin C as a Probe for Imaging Redox Status in Vivo , 2011, Journal of the American Chemical Society.

[50]  C. James,et al.  Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging , 2011, Journal of magnetic resonance imaging : JMRI.

[51]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[52]  John Kurhanewicz,et al.  Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. , 2011, Neoplasia.

[53]  James B. Mitchell,et al.  Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1‐13C]pyruvate and 13C magnetic resonance spectroscopic imaging , 2011, Magnetic resonance in medicine.

[54]  R. Lenkinski,et al.  On-target inhibition of tumor fermentative glycolysis as visualized by hyperpolarized pyruvate. , 2011, Neoplasia.

[55]  F. Gallagher,et al.  Detection of Tumor Response to a Vascular Disrupting Agent by Hyperpolarized 13C Magnetic Resonance Spectroscopy , 2010, Molecular Cancer Therapeutics.

[56]  F. Gallagher,et al.  Detecting treatment response in a model of human breast adenocarcinoma using hyperpolarised [1-13C]pyruvate and [1,4-13C2]fumarate , 2010, British Journal of Cancer.

[57]  S. Meier,et al.  Imaging of branched chain amino acid metabolism in tumors with hyperpolarized 13C ketoisocaproate , 2010, International journal of cancer.

[58]  Adam B Kerr,et al.  Investigation of tumor hyperpolarized [1‐13C]‐pyruvate dynamics using time‐resolved multiband RF excitation echo‐planar MRSI , 2010, Magnetic resonance in medicine.

[59]  J. Allison,et al.  PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors , 2010, Proceedings of the National Academy of Sciences.

[60]  John Kurhanewicz,et al.  Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy. , 2010, Cancer research.

[61]  B. Ross,et al.  Cardiovascular Applications of Hyperpolarized Contrast Media and Metabolic Tracers , 2009, Experimental biology and medicine.

[62]  Sarah E Bohndiek,et al.  Production of hyperpolarized [1,4-13C2]malate from [1,4-13C2]fumarate is a marker of cell necrosis and treatment response in tumors , 2009, Proceedings of the National Academy of Sciences.

[63]  John Kurhanewicz,et al.  Hyperpolarized [2-13C]-fructose: a hemiketal DNP substrate for in vivo metabolic imaging. , 2009, Journal of the American Chemical Society.

[64]  K. D. Atkinson,et al.  Reversible Interactions with para-Hydrogen Enhance NMR Sensitivity by Polarization Transfer , 2009, Science.

[65]  Kent Harris,et al.  PASADENA hyperpolarization of succinic acid for MRI and NMR spectroscopy. , 2008, Journal of the American Chemical Society.

[66]  Kevin Brindle,et al.  New approaches for imaging tumour responses to treatment , 2008, Nature Reviews Cancer.

[67]  Jan Wolber,et al.  Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy , 2007, Nature Medicine.

[68]  Jan Henrik Ardenkjaer-Larsen,et al.  Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis. , 2006, Cancer research.

[69]  Bruce D Cheson,et al.  Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development , 2005, Clinical Cancer Research.

[70]  J. Ardenkjær-Larsen,et al.  Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[71]  Daniel P. Weitekamp,et al.  Parahydrogen and synthesis allow dramatically enhanced nuclear alignment , 1987 .

[72]  I. Campbell,et al.  Studies of lactate dehydrogenase in the purified state and in intact erythrocytes. , 1982, The Biochemical journal.

[73]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.